JP2023540098A5 - - Google Patents
Info
- Publication number
- JP2023540098A5 JP2023540098A5 JP2023514458A JP2023514458A JP2023540098A5 JP 2023540098 A5 JP2023540098 A5 JP 2023540098A5 JP 2023514458 A JP2023514458 A JP 2023514458A JP 2023514458 A JP2023514458 A JP 2023514458A JP 2023540098 A5 JP2023540098 A5 JP 2023540098A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- sequence
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074418P | 2020-09-03 | 2020-09-03 | |
| US63/074,418 | 2020-09-03 | ||
| PCT/US2021/048943 WO2022051555A2 (en) | 2020-09-03 | 2021-09-02 | Soluble alkaline phosphatase constructs and expression vectors including a polynucleotide encoding for soluble alkaline phosphatase constructs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023540098A JP2023540098A (ja) | 2023-09-21 |
| JP2023540098A5 true JP2023540098A5 (enExample) | 2024-09-09 |
Family
ID=78676616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514458A Pending JP2023540098A (ja) | 2020-09-03 | 2021-09-02 | 可溶性アルカリホスファターゼ構築物及び可溶性アルカリホスファターゼ構築物をコードするポリヌクレオチドを含む発現ベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240150737A1 (enExample) |
| EP (1) | EP4203989A2 (enExample) |
| JP (1) | JP2023540098A (enExample) |
| KR (1) | KR20230117327A (enExample) |
| CN (1) | CN116848146A (enExample) |
| AU (1) | AU2021338361A1 (enExample) |
| CA (1) | CA3190513A1 (enExample) |
| WO (1) | WO2022051555A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025525583A (ja) | 2022-07-19 | 2025-08-05 | ランパート バイオサイエンス インコーポレイテッド | 非免疫原性環状非ウイルス性ｄｎａベクター |
| WO2025090786A1 (en) * | 2023-10-24 | 2025-05-01 | Rampart Bioscience, Inc. | Reduced immunogenic gene therapy protocols using circular, extended cruciform containing non-viral vectors |
| WO2025097067A2 (en) * | 2023-11-02 | 2025-05-08 | Be Biopharma, Inc. | Engineered cell preparations for treatment of hypophosphatasia |
| AU2024407494A1 (en) * | 2023-12-19 | 2026-07-23 | Evotec International Gmbh | Plasmids, transgenes, vectors and medical uses comprising tissue non-specific alkaline phosphatase |
| WO2026089719A1 (en) * | 2024-10-24 | 2026-04-30 | Rampart Bioscience, Inc. | Dna vectors having specialized secondary structures for use in treating hypophosphatasia |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4579821A (en) | 1981-11-23 | 1986-04-01 | University Patents, Inc. | Control of DNA sequence transcription |
| US4656134A (en) | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| US4601978A (en) | 1982-11-24 | 1986-07-22 | The Regents Of The University Of California | Mammalian metallothionein promoter system |
| US4713339A (en) | 1983-01-19 | 1987-12-15 | Genentech, Inc. | Polycistronic expression vector construction |
| GR860984B (en) | 1985-04-17 | 1986-08-18 | Zymogenetics Inc | Expression of factor vii and ix activities in mammalian cells |
| US4956288A (en) | 1988-04-22 | 1990-09-11 | Biogen, Inc. | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA |
| US5422120A (en) | 1988-05-30 | 1995-06-06 | Depotech Corporation | Heterovesicular liposomes |
| ZA911974B (en) | 1990-03-21 | 1994-08-22 | Res Dev Foundation | Heterovesicular liposomes |
| AU6818094A (en) | 1993-04-22 | 1994-11-08 | Depotech Corporation | Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
| HUT75162A (en) | 1993-11-16 | 1997-04-28 | Depotech Corp | Vesicles with controlled release of actives |
| IL112372A (en) | 1994-02-07 | 2001-08-26 | Res Dev Foundation | Non-viral vector for the delivery of genetic information to cells |
| CA2264482A1 (en) | 1996-09-06 | 1998-03-12 | The Trustees Of The University Of Pennsylvania | An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase |
| US6218181B1 (en) | 1998-03-18 | 2001-04-17 | The Salk Institute For Biological Studies | Retroviral packaging cell line |
| GB0024827D0 (en) * | 2000-10-10 | 2000-11-22 | Norwegian Inst Of Fisheries & | Product |
| US7575924B2 (en) | 2000-11-13 | 2009-08-18 | Research Development Foundation | Methods and compositions relating to improved lentiviral vectors and their applications |
| US7510877B2 (en) | 2003-09-26 | 2009-03-31 | The Regents Of The University Of Michigan | Hematopoietic stem cell identification and isolation |
| PL1759001T3 (pl) * | 2004-04-21 | 2011-09-30 | Alexion Pharma Inc | Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości |
| WO2005123142A1 (en) | 2004-06-10 | 2005-12-29 | Abraxis Bioscience, Inc. | A method using inorganic nanoparticles as non-viral vectors for gene therapy |
| EP2573185A3 (en) | 2005-02-16 | 2013-06-05 | Lentigen Corporation | Lentiviral vectors and their use |
| DE102005023993A1 (de) | 2005-05-20 | 2006-11-23 | TransMIT Gesellschaft für Technologietransfer mbH | Nicht virales Vektorsystem zum Transport von Nukleinsäure in die Lunge |
| GB0702695D0 (en) | 2007-02-12 | 2007-03-21 | Ark Therapeutics Ltd | Production of vectors |
| DK2662448T3 (en) * | 2007-05-11 | 2017-03-20 | Alexion Pharma Inc | Bone-targeted alkaline phosphatase, kits and methods for its use |
| US20090098055A1 (en) * | 2007-08-23 | 2009-04-16 | Intrexon Corporation | Methods and Compositions for Diagnosing Disease |
| ES2374245B1 (es) | 2010-08-02 | 2012-12-26 | Universidad Castilla La Mancha | Vectores no virales para terapia génica. |
| ES2374243B1 (es) | 2010-08-02 | 2012-12-26 | Universidad Castilla-La Mancha | Vectores no virales para terapia génica. |
| KR20140084201A (ko) * | 2011-10-19 | 2014-07-04 | 알렉시온 파마 홀딩 | 알칼리성 포스파타제 및/또는 나트륨이뇨 펩티드를 포함하는 조성물 및 그의 사용 방법 |
| CN103316356B (zh) | 2012-03-22 | 2016-08-17 | 北京三诺佳邑生物技术有限责任公司 | 一种重组慢病毒载体制剂 |
| US10052366B2 (en) * | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| GB201220119D0 (en) | 2012-11-08 | 2012-12-26 | Univ Cork | Vector |
| WO2016007873A1 (en) * | 2014-07-11 | 2016-01-14 | The Regents Of The University Of Michigan | Compositions and methods for treating craniosynostosis |
| FR3024464A1 (fr) | 2014-07-30 | 2016-02-05 | Centre Nat Rech Scient | Ciblage de vecteurs integratifs non-viraux dans les sequences d'adn nucleolaires chez les eucaryotes |
| JP6787894B2 (ja) * | 2014-12-05 | 2020-11-18 | アレクシオン ファーマシューティカルズ， インコーポレイテッド | 組換えアルカリホスファターゼを用いた発作の処置 |
| IL266977B2 (en) * | 2016-11-30 | 2024-01-01 | Purdue Research Foundation | Fracture-targeted bone regeneration using thyroid hormone receptor stimulation |
| BR112021009913A2 (pt) * | 2018-12-05 | 2021-08-17 | Abeona Therapeutics, Inc. | vetor viral adeno-associado recombinante para inserção gênica |
-
2021
- 2021-09-02 JP JP2023514458A patent/JP2023540098A/ja active Pending
- 2021-09-02 KR KR1020237010663A patent/KR20230117327A/ko active Pending
- 2021-09-02 AU AU2021338361A patent/AU2021338361A1/en active Pending
- 2021-09-02 CA CA3190513A patent/CA3190513A1/en active Pending
- 2021-09-02 CN CN202180066467.4A patent/CN116848146A/zh active Pending
- 2021-09-02 WO PCT/US2021/048943 patent/WO2022051555A2/en not_active Ceased
- 2021-09-02 EP EP21810456.0A patent/EP4203989A2/en active Pending
-
2023
- 2023-02-27 US US18/114,528 patent/US20240150737A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Persson et al. | Prediction of membrane protein topology utilizing multiple sequence alignments | |
| JP2006149395A5 (enExample) | ||
| Odermatt et al. | Repeating modular structure of the fibronectin gene: relationship to protein structure and subunit variation. | |
| JP2022554300A5 (enExample) | ||
| KR910003101A (ko) | β-1, 3-글루카나제 활성을 갖는 폴리펩티드를 코딩하는 DNA 서열 | |
| JP2007513634A5 (enExample) | ||
| RU2001103131A (ru) | Уратоксидаза | |
| JP2023554379A5 (enExample) | ||
| WO2022232327A3 (en) | Aav capsids and uses thereof | |
| RU2006105498A (ru) | Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus | |
| ATE350049T1 (de) | Zusammensetzungen und verfahren zur behinderung der vervielfältigung von hiv-1 | |
| JP2022529021A5 (enExample) | ||
| Martenson | Prediction of the secondary structure of myelin basic protein | |
| JP2002514418A5 (enExample) | ||
| EP1401477A4 (en) | Chemokine Beta-1 FUSION PROTEIN | |
| JP2020536489A5 (enExample) | ||
| EP1090122B1 (fr) | Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains, et leurs applications | |
| CA2461443A1 (en) | Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use | |
| JP2023171909A5 (enExample) | ||
| Ohmachi et al. | Molecular organization of developmentally regulated Dictyostelium discoideum ubiquitin cDNAs | |
| Drewlo et al. | C-Terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity. | |
| Parvari et al. | Analyses of chicken immunoglobulin light chain cDNA clones indicate a few germline V lambda genes and allotypes of the C lambda locus. | |
| JP2019531100A5 (enExample) | ||
| Penadés et al. | Characterization and expression of multiple alternatively spliced transcripts of the Goodpasture antigen gene region: Goodpasture antibodies recognize recombinant proteins representing the autoantigen and one of its alternative forms | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe |